Sponsor:
Institut de Recherches Cliniques de Montreal
Code:
NCT07322380
Conditions
Type 1 Diabetes (T1D)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Centralized Monitoring Approach
Decentralized Monitoring Approach
Brief summary:
Conditions
Type 1 Diabetes (T1D)
Study ID
NCT07322380
Start date
Sep 1, 2026
Status verified date
Oct, 2026
Completion date
Mar 31, 2028
Anticipated
Primary completion date
Feb 1, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
1000 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Screening
Arms
active comparator: Centralized approach
active comparator: Decentralized approach
Interventions
Centralized Monitoring Approach
Decentralized Monitoring Approach
Primary outcome measure
Central contacts
Maha Lebbar, M.D.
maha.lebbar@ircm.qc.caLocations
Institut de recherches cliniques de Montréal
Recruiting
Montreal, Quebec, Canada, H2W 1R7
Contacts
Sponsor
Institut de Recherches Cliniques de Montreal
Last update posted
Nov 17, 2026
Last verified
Oct, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-18. This information was provided to ClinicalTrials.gov by Institut de Recherches Cliniques de Montreal on 2026-11-17. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.